Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | -0.44% | +7.04% | -34.10% |
May. 09 | Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 15.99M | Sales 2025 * | 18.05M | Capitalization | 24.04M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
-65.1
x | P/E ratio 2025 * |
57
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.3% |
Latest transcript on Nephros, Inc.
1 day | -0.44% | ||
1 week | +7.04% | ||
Current month | +2.24% | ||
1 month | +8.57% | ||
3 months | -34.86% | ||
6 months | +3.64% | ||
Current year | -34.10% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 23-03-30 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | Oct. 31 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 07-09-18 |
Oliver Spandow
BRD | Director/Board Member | 52 | 18-08-09 |
Alisa Lask
BRD | Director/Board Member | 53 | 19-02-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 2.28 | -0.44% | 12,714 |
24-05-20 | 2.29 | -2.97% | 5,710 |
24-05-17 | 2.36 | +3.97% | 60,174 |
24-05-16 | 2.27 | +10.73% | 64,409 |
24-05-15 | 2.05 | -3.76% | 5,789 |
Delayed Quote Nasdaq, May 21, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.10% | 24.04M | |
+14.98% | 9.04B | |
+35.62% | 2.4B | |
-13.08% | 1.04B | |
+24.31% | 881M | |
-5.16% | 775M | |
+23.96% | 730M | |
+28.21% | 741M | |
-18.27% | 577M | |
+15.52% | 575M |
- Stock Market
- Equities
- NEPH Stock